Indole-3-Carbinol in Preventing Cancer in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

November 30, 2004

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

indole-3-carbinol

Trial Locations (1)

Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center, Kansas City

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Kansas

OTHER

NCT00100958 - Indole-3-Carbinol in Preventing Cancer in Healthy Participants | Biotech Hunter | Biotech Hunter